Overall, the findings reported in this comprehensive review of the literature indicate that flortaucipir is an accurate and useful in vivo marker of tau pathology that can improve the diagnostic, and potentially prognostic, landscape for Alzheimer’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.